Common Contracts
2 similar Co-Development and Marketing Agreement contracts
Ono and Seikagaku Reach a Definitive Agreement Related to Co-development and Marketing Collaboration on SI-613Co-Development and Marketing Agreement • August 30th, 2017
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; “Ono”) and Seikagaku Corporation (Tokyo, Japan; “Seikagaku”) announced that they have reached a definitive agreement (“the agreement”) related to co-development and marketing collaboration on SI-613 in Japan under development by Seikagaku for the treatment of osteoarthritis. The agreement is based on the basic agreement reached on May 12, 2017.
Ono and Seikagaku Reach a Definitive Agreement Related to Co-development and Marketing Collaboration on SI-613Co-Development and Marketing Agreement • August 30th, 2017
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; “Ono”) and Seikagaku Corporation (Tokyo, Japan; “Seikagaku”) announced that they have reached a definitive agreement (“the agreement”) related to co-development and marketing collaboration on SI-613 in Japan under development by Seikagaku for the treatment of osteoarthritis. The agreement is based on the basic agreement reached on May 12, 2017.
